Dudediligence.

Onconetix, Inc

ONCONASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$645,824last 12 months
Net income
−$10.2Mlast 12 months
Operating cash flow
−$9.8Mlast 12 months
Cash and equivalents
$5.9Mat the last balance sheet
Shares outstanding
3.8M shareson issue
Every year and quarter →